Sandra M. Swain
- Oncology top 0.02%
- HER2/EGFR in Cancer Research 138
- Cancer Treatment and Pharmacology 134
- Peptidase Inhibition and Analysis 20
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies 123
-
- Monoclonal and Polyclonal Antibodies Research 37
- Pulmonary and Respiratory Medicine top 0.2%
- Advanced Breast Cancer Therapies 58
-
- Chemotherapy-induced cardiotoxicity and mitigation 20
-
- Estrogen and related hormone effects 26
- Co-authors
- José BaselgaMichael S. EwerFredrick S. WhaleyJavier CortésEmma ClarkGraham RossNorman WolmarkMark Benyunes
- Journals
- Journal of Clinical Oncology (97 papers)Breast Cancer Research and Treatment (23 papers)Cancer Research (19 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Sandra M. Swain
328 papers receiving 22.8k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Oncology 15.4k
- Cancer Research 7.2k
- Radiology, Nuclear Medicine and Imaging 4.9k
- Pulmonary and Respiratory Medicine 4.8k
- Cardiology and Cardiovascular Medicine 3.3k
Countries citing papers authored by Sandra M. Swain
This map shows the geographic impact of Sandra M. Swain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra M. Swain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra M. Swain more than expected).
Fields of papers citing papers by Sandra M. Swain
This network shows the impact of papers produced by Sandra M. Swain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra M. Swain. The network helps show where Sandra M. Swain may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sandra M. Swain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 4 | |
| 8 | 2019 | 23 | |
| 9 | 2019 | 24 | |
| 10 | 2017 | 25 | |
| 11 | 2013 | 64 | |
| 12 | Treatment and cost implications of pertuzumab. | 2012 | 2 |
| 13 | 2010 | 10 | |
| 14 | 2010 | 104 | |
| 15 | 2008 | 69 | |
| 16 | 2005 | 26 | |
| 17 | Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31breakdown → | 2005 | 568 |
| 18 | 2003 | 437 | |
| 19 | Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer. | 2002 | 64 |
| 20 | Heterogeneous expression of erbB-2 messenger RNA in human breast cancer. | 1989 | 56 |
About Sandra M. Swain
Sandra M. Swain is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 337 papers that have together received 23.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (138 papers), Cancer Treatment and Pharmacology (134 papers), Breast Cancer Treatment Studies (123 papers), Advanced Breast Cancer Therapies (58 papers), Monoclonal and Polyclonal Antibodies Research (37 papers), Estrogen and related hormone effects (26 papers), Peptidase Inhibition and Analysis (20 papers) and Chemotherapy-induced cardiotoxicity and mitigation (20 papers). The work is most often cited by research in Oncology (15.4k citations), Cancer Research (7.2k citations) and Radiology, Nuclear Medicine and Imaging (4.9k citations). Sandra M. Swain has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include José Baselga, Michael S. Ewer, Fredrick S. Whaley, Javier Cortés, Emma Clark, Graham Ross, Norman Wolmark, Mark Benyunes, James J. Lee and Sung‐Bae Kim. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, Clinical Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.